Toshimasa Asahara
Overview
Explore the profile of Toshimasa Asahara including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
125
Citations
2275
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Kawaguchi Y, Tashiro H, Amano H, Kobayashi T, Irei T, Igarashi Y, et al.
Hepatol Res
. 2010 Sep;
39(5):520-4.
PMID: 20849569
Budd-Chiari syndrome (BCS) results from diverse causative factors. Myeloproliferative disorders (MPDs) including essential thrombocythemia (ET) account for a minority of BCS cases in Japan. ABO-blood-type incompatible living donor liver transplantation...
12.
Utoh R, Tateno C, Kataoka M, Tachibana A, Masumoto N, Yamasaki C, et al.
Am J Pathol
. 2010 Jun;
177(2):654-65.
PMID: 20522646
Liver mass is optimized in relation to body mass. Rat (r) and human (h) hepatocytes were transplanted into liver-injured immunodeficient mice and allowed to proliferate for 3 or 11 weeks,...
13.
Oda M, Arihiro K, Kataoka T, Osaki A, Asahara T, Ohdan H
Pathol Int
. 2010 Apr;
60(4):305-15.
PMID: 20403033
The estrogen receptor (ER) and progesterone receptor (PgR) status of 163 surgical breast cancer specimens determined on real-time quantitative reverse transcription-polymerase chain reaction (RT-PCR) using frozen tumor tissue were compared...
14.
Oshita A, Bachellier P, Rosso E, Oussoultzoglou E, Lucescu I, Asahara T, et al.
Hepatogastroenterology
. 2009 Dec;
56(94-95):1507-10.
PMID: 19950818
Ill-located liver metastases close to the cavo-hepatic confluence often require resection and reconstruction of hepatic veins. However, most of the current techniques for reconstruction of the hepatic veins require graft...
15.
Ushitora Y, Tashiro H, Ogawa T, Tanimoto Y, Kuroda S, Kobayashi T, et al.
Transplantation
. 2009 Oct;
88(8):980-6.
PMID: 19855243
BACKGROUND.: Although the outcome of liver transplant patients with hepatocellular carcinoma (HCC) has improved with the introduction of strict criteria, tumor recurrence still remains a significant problem. Sphingosine-1-phosphate (S1P) is...
16.
Ohira M, Ishiyama K, Tanaka Y, Doskali M, Igarashi Y, Tashiro H, et al.
J Clin Invest
. 2009 Oct;
119(11):3226-35.
PMID: 19805910
After liver transplantation in HCV-infected patients, the virus load inevitably exceeds pre-transplantation levels. This phenomenon reflects suppression of the host-effector immune responses that control HCV replication by the immunosuppressive drugs...
17.
Nishie M, Tateno C, Utoh R, Kohashi T, Masumoto N, Kobayashi N, et al.
Cell Transplant
. 2009 Sep;
18(5):665-75.
PMID: 19775529
Hepatocyte transplantation is effective for treating liver failure, but healthy donors as a source of hepatocytes are quite limited. The livers of patients with hepatic fibrosis could be an alternative...
18.
Tahara H, Tanaka Y, Ishiyama K, Ide K, Shishida M, Irei T, et al.
Transpl Int
. 2009 Jun;
22(8):805-13.
PMID: 19490542
Currently, patients are prescribed lifelong treatment with hepatitis B immunoglobulin (HBIg) after liver transplantation (LT) for hepatitis B virus (HBV)-related diseases in order to prevent reinfection with HBV. Active immunization...
19.
Ohira M, Ishifuro M, Ide K, Irei T, Tashiro H, Itamoto T, et al.
Liver Transpl
. 2009 Jan;
15(2):208-15.
PMID: 19177451
Interferon (IFN) therapy with or without ribavirin treatment is well established as a standard antiviral treatment for hepatitis C virus (HCV)-infected patients. However, susceptibility to thrombocytopenia is a major obstacle...
20.
Kawaoka T, Takahashi S, Aikata H, Azakami T, Saneto H, Takaki S, et al.
J Gastroenterol
. 2008 Dec;
43(12):982-9.
PMID: 19107343
Background: Liver transplantation (LT) is known to improve bleeding esophageal varices (EVs) and portal hypertension. However, many issues related to EVs after LT remain unresolved, such as whether LT reduces...